Original Research Article
Very Mild to Severe Dementia and Mortality: A 14-Year Follow-Up – The Odense StudyAndersen K.a, c · Lolk A.a, c · Martinussen T.b · Kragh-Sørensen P.c
aDepartment of Psychiatry, Odense University Hospital, bResearch Unit of Biostatistics, Institute of Public Health, Faculty of Health Sciences, and cInstitute of Clinical Research, University of Southern Denmark, Odense, Denmark
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Background/Aims: To examine the mortality of very mildly to severely demented persons compared to nondemented persons. Methods: Participants in a randomly drawn population-based cohort study on dementia were followed for 14 years from 1992 to 2006. Participants were examined at baseline (3,065 nondemented and 234 prevalent demented), after 2 years (2,286 nondemented and 145 incident demented) and again after 5 years (1,669 nondemented and 124 new cases of dementia). Causes of death were ascertained in 884 nondemented and 286 demented participants. Survival for demented compared to nondemented persons was analyzed with the Cox proportional hazards model with time-dependent covariates adjusted for gender and age. Results: The hazard ratio of death (95% confidence interval) increased from 1.82 (1.55–2.14) for the very mildly demented to 9.52 (6.60–13.74) for the severely demented subjects. The demented participants died significantly more often of neurological causes other than dementia and of pneumonia than the nondemented participants. No other significant differences in causes of death were found. Conclusion: Dementia increased the risk of death. Even in the very early stages of dementia the risk of death was increased.
© 2010 S. Karger AG, Basel
- Baldereschi M, Di Carlo A, Maggi S, Grigoletto F, Scarlato G, Amaducci L, Inzitari D: Dementia is a major predictor of death among the Italian elderly. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 1999;52:709–713.
- Helmer C, Joly P, Letenneur L, Commenges D, Dartigues JF: Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol 2001;154:642–648.
- Wolfson C, Wolfson DB, Asgharian M, M’Lan CE, Ostbye T, Rockwood K, Hogan DB: A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001;344:1111–1116.
- Tschanz JT, Corcoran C, Skoog I, Khachaturian AS, Herrick J, Hayden KM, Welsh-Bohmer KA, Calvert T, Norton MC, Zandi P, Breitner JC: Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. Neurology 2004;62:1156–1162.
- Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST: Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol 2005;62:779–784.
- Nitrini R, Caramelli P, Herrera E Jr, de Castro I, Bahia VS, Anghinah R, Caixeta LF, Radanovic M, Charchat-Fichman H, Porto CS, Teresa Carthery M, Hartmann AP, Huang N, Smid J, Lima EP, Takahashi DY, Takada LT: Mortality from dementia in a community-dwelling Brazilian population. Int J Geriatr Psychiatry 2005;20:247–253.
- Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol 1998;55:1226–1232.
- Storandt M, Grant EA, Miller JP, Morris JC: Rates of progression in mild cognitive impairment and early Alzheimer’s disease. Neurology 2002;59:1034–1041.
- Llinas-Regla J, Lopez-Pousa S, Vilalta-Franch J, Garre-Olmo J, Roman GC: Mortality after a diagnosis of dementia in a population aged 75 and over in Spain. Neuroepidemiology 2008;31:80–88.
- Attems J, Konig C, Huber M, Lintner F, Jellinger KA: Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. J Alzheimers Dis 2005;8:57–62.
- Ostbye T, Hill G, Steenhuis R: Mortality in elderly Canadians with and without dementia: a 5-year follow-up. Neurology 1999;53:521–526.
- Andersen K, Lolk A, Nielsen H, Andersen J, Olsen C, Kragh-Sørensen P: Prevalence of very mild to severe dementia in Denmark. Acta Neurol Scand 1997;96:82–87.
- Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R: CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698–709.
- Ganguli M, Ratcliff G, Huff FJ, Belle S, Kancel MJ, Fischer L, Seaberg EC, Kuller LH: Effects of age, gender, and education on cognitive tests in a rural elderly community sample: norms from the Monongahela Valley Independent Elders Survey. Neuroepidemiology 1991;10:42–52.
- Huppert FA, Brayne C, Gill C, Paykel ES, Beardsall L: CAMCOG – A concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol 1995;34:529–541.
- Lindeboom J, Ter HR, Hooyer C, Dinkgreve M, Jonker C: Some psychometric properties of the CAMCOG. Psychol Med 1993;23:213–219.
- Lolk A, Nielsen H, Andersen K, Andersen J, Kragh-Sorensen P: CAMCOG as a screening instrument for dementia: the Odense study. Cambridge Cognitive Examination. Acta Psychiatr Scand 2000;102:331–335.
Nielsen H, Lolk A, Kragh-Sørensen P: Normative data for eight neuropsychological tests, gathered from a random sample of Danes aged 64 to 83 years. Nord Psyk 1995;47:241–255.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington, American Psychiatric Association, 1987.
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
- Berg L: Clinical Dementia Rating (CDR). Psychopharmacol Bull 1988;24:637–639.
- Andersen K, Nielsen H, Lolk A, Andersen J, Becker I, Kragh-Sørensen P: Incidence of very mild to severe dementia and Alzheimer’s disease in Denmark. The Odense Study. Neurology 1999;52:85–90.
- Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A: Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. EURODEM Incidence Research Group. Neurology 1999;53:1992–1997.
- Desmond DW, Tatemichi TK, Paik M, Stern Y: Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993;50:162–166.
- Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, van Harskamp F, Tanghe HL, de Jong PT, van Gijn J, Hofman A: Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246–1252.
- Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H: The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005;28:2130–2135.
- Stewart R, Liolitsa D: Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999;16:93–112.
- Klatsky AL, Udaltsova N: Alcohol drinking and total mortality risk. Ann Epidemiol 2007;17:S63–S67.
- Peters R, Peters J, Warner J, Beckett N, Bulpitt C: Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 2008;37:505–512.
- Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004;328:1519.
- Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, van Duijn CM, Breteler MM: Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam Study. Lancet 1998;351:1840–1843.
- Jorm AF: Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 2000;46:219–227.
- Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB: Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 2007;68:899–907.
- Lin DY, Wei LJ, Ying Z: Checking the Cox model with cumulative sum of martingale-based residuals. Biometika 1993;80:557–572.
- Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA: Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004;140:501–509.
- Waring SC, Doody RS, Pavlik VN, Massman PJ, Chan W: Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord 2005;19:178–183.
- Guhne U, Matschinger H, Angermeyer MC, Riedel-Heller SG: Incident dementia cases and mortality. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Dement Geriatr Cogn Disord 2006;22:185–193.
- Williams MM, Xiong C, Morris JC, Galvin JE: Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology 2006;67:1935–1941.
- Chamandy N, Wolfson C: Underlying cause of death in demented and non-demented elderly Canadians. Neuroepidemiology 2005;25:75–84.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
- Brookmeyer R, Corrada MM, Curriero FC, Kawas C: Survival following a diagnosis of Alzheimer disease. Arch Neurol 2002;59:1764–1767.
- Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST: Cholinesterase inhibitor treatment alters the natural history of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2002;72:310–314.
- Lopez OL, Becker JT, Wahed AS, Saxton J, Sweet RA, Wolk DA, Klunk W, Dekosky ST: Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease. J Neurol Neurosurg Psychiatry 2009;80:600–607.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.